Clinical Trials Logo
  1. Home
  2. Bone Cancer
  3. NCT01313884

Cyclophosphamide, Doxorubicin, Vincristine w/ Irinotecan and Temozolomide in Ewings Sarcoma

Bone Cancer Clinical Trial

Official title:
A Phase II Pilot Study of Cyclophosphamide, Doxorubicin, Vincristine Alternating With Irinotecan and Temozolomide in Patients With Newly Diagnosed Metastatic Ewing's Sarcoma

Clinical Trial Summary

The outcome of patients with metastatic Ewings Sarcoma is poor with current standard of care chemotherapy, with less than 30% survival. Based on recent encouraging pediatric literature we have designed this trial to improve the outcome of patients with metastatic Ewings sarcoma using Irinotecan and Temozolomide in addition to standard chemotherapy.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT01313884
Study type Interventional
Source Stanford University
Contact
Status Terminated
Phase Phase 2
Start date May 2011
Completion date July 2014
View Details
See also
  Status Clinical Trial Phase
Recruiting NCT03905174 - Massive Implants the Next Generation N/A
Completed NCT00160719 - HLA Sensitization Following Major Cortical Allograft Bone Procedures Phase 4
Completed NCT04974008 - Osteosarcoma Maintenance Therapy With OST31-164 Phase 2
Not yet recruiting NCT06070259 - Insights Into Participating in Studies for Bone Cancer
Completed NCT01553539 - Therapeutic Angiotensin-(1-7) in Treating Patients With Metastatic Sarcoma That Cannot Be Removed By Surgery Phase 2
Recruiting NCT03160274 - Genetic Analysis of Pheochromocytomas, Paragangliomas and Associated Conditions
Active, not recruiting NCT02880319 - Evaluating Stereotactic Body Radiation Therapy for Oligometastatic Disease of the Bone Phase 2
Completed NCT01135849 - B-Receptor Signaling in Cardiomyopathy N/A
Terminated NCT00960063 - A Study of Robatumumab (SCH 717454, MK-7454) in Combination With Different Treatment Regimens in Pediatric Participants With Advanced Solid Tumors (P05883, MK-7454-006) Phase 1
Terminated NCT02443103 - Study Evaluating the Biologic Activity of Guanabenz in Bone Metastasis N/A
Recruiting NCT04028479 - The Registry of Oncology Outcomes Associated With Testing and Treatment
Terminated NCT03525392 - Study to Evaluate the Safety and Activity (Including Distribution) of 177Lu-3BP-227 in Subjects With Solid Tumours Expressing Neurotensin Receptor Type 1. Phase 1
Terminated NCT01541358 - Sodium Fluoride PET/CT for the Evaluation of Skeletal Cancer N/A
Completed NCT01091883 - Study Comparing the Safety and Effectiveness of Magnetic Resonance Guided Focused Ultrasound (MRgFUS) and External Beam Radiation (EBRT) for Treatment of Metastatic Bone Tumors and Multiple Myeloma N/A
Terminated NCT00127387 - Enbrel Versus Placebo With Radiation Therapy to Combat Fatigue and Cachexia Phase 2/Phase 3
Not yet recruiting NCT03106675 - MR Imaging- Guided High Intensity Focused Ultrasound (HIFU) Therapy of Bone Metastases N/A
Recruiting NCT05830084 - Phase Ib / Regorafenib With Conventional Chemotherapy/Newly Diagnosed Patients/ Multimetastatic Ewing Sarcoma Phase 1
Completed NCT01085565 - Focused Ultrasound Surgery in the Treatment of Pain Resulting From Metastatic Bone Tumors With the ExAblate 2100 Conformal Bone System Phase 2
Recruiting NCT04307914 - Focused Ultrasound and RadioTHERapy for Noninvasive Palliative Pain Treatment in Patients With Bone Metastases N/A
Terminated NCT01163539 - Cyberknife Radiosurgery and Quality of Life N/A